These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17602145)

  • 21. Erythropoiesis and erythrocyte age distribution in hemodialysis patients undergoing erythropoietin therapy.
    Hampl H; Riedel E; Scigalla P; Stabell U; Wendel G
    Blood Purif; 1990; 8(3):117-25. PubMed ID: 2244989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis.
    Winkelmayer WC
    Semin Dial; 2010; 23(5):486-91. PubMed ID: 21069924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemoglobin F levels in end-stage renal disease patients after correction of anemia with erythropoietin.
    Sikole A; Efremov DG; Dimovski A; Efremov GD; Polenakovic M
    Nephron; 1993; 65(3):482-4. PubMed ID: 7507224
    [No Abstract]   [Full Text] [Related]  

  • 24. Managing anemia in dialysis patients: hemoglobin cycling and overshoot.
    Singh AK; Milford E; Fishbane S; Keithi-Reddy SR
    Kidney Int; 2008 Sep; 74(5):679-83. PubMed ID: 18337717
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of human recombinant erythropoietin on plasminogen activator inhibitor, and protein C and S activity.
    Steffensen G; Aunsholt NA
    Am J Nephrol; 1996; 16(5):453-4. PubMed ID: 8886186
    [No Abstract]   [Full Text] [Related]  

  • 26. Association between haemoglobin and neopterin concentrations in haemodialysis patients treated with erythropoietin.
    Diez-Ruiz A; Weiss G; Artner-Dworzak E; Dittrich PV; Wachter H; Fuchs D
    Eur J Haematol; 1993 Sep; 51(3):175-6. PubMed ID: 8405333
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of renal anemia with erythropoietin].
    Spustova V; Kovac A
    Bratisl Lek Listy; 1999 Aug; 100(8):432-8. PubMed ID: 10645031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of anaemia in chronic renal failure.
    Beer J
    Nurs Times; 1988 Nov 23-29; 84(47):55-7. PubMed ID: 3211795
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.
    Yong K; Kairaitis L
    Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis.
    Salvati F; Strippoli P; Barchetti M; Scatizzi A
    Nephron; 1992; 60(3):371. PubMed ID: 1373475
    [No Abstract]   [Full Text] [Related]  

  • 31. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin.
    Eschbach JW
    Kidney Int; 1989 Jan; 35(1):134-48. PubMed ID: 2651751
    [No Abstract]   [Full Text] [Related]  

  • 32. Darbepoetin alfa: a novel erythropoiesis-stimulating protein.
    Cases A
    Drugs Today (Barc); 2003 Jul; 39(7):477-95. PubMed ID: 12973399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.
    Foley RN; Curtis BM; Parfrey PS
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1669-75. PubMed ID: 18922988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
    Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R
    J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of erythropoiesis stimulating agent in ESRD.
    Fishbane S; Shah HH
    Nephrol News Issues; 2013 Jun; 27(7):Supp 10-2. PubMed ID: 23855143
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of anemia caused by chronic kidney failure in adults].
    Nephrol Ther; 2005 Aug; 1 Suppl 1():S1-48. PubMed ID: 16895707
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
    Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
    Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure.
    Maxwell AP
    Kidney Int; 2002 Aug; 62(2):720-9. PubMed ID: 12110039
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of angiotensin-converting enzyme inhibitors on anemia in hemodialyzed patients.
    Teruel JL; Fernandez Juarez G; Marcen R; Nogueira J; Ortuño J
    Nephron; 1996; 73(1):113. PubMed ID: 8742977
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythropoietin treatment: influence of haemoglobin concentration on dialyser creatinine clearance in haemodialysed patients.
    Zehnder C
    Nephron; 1989; 51(3):424-5. PubMed ID: 2918959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.